Vaccination herd effect experience in Latin America: a systematic literature review

Vaccination herd effect experience in Latin America: a systematic literature review

Background: National pediatric vaccination programs have been introduced in Latin America (LatAm) to reduce the burden of diseases due to pathogens such as rotavirus, Haemophilus influenzae type b (Hib) and pneumococcus. Vaccination health benefits may extend to unvaccinated populations by reducing...

Full description

Bibliographic Details
Main Authors:	Rodrigo DeAntonio, Sylvia Amador, Eveline M. Bunge, Jennifer Eeuwijk, David Prado-Cohrs, Javier Nieto Guevara, Maria del Pilar Rubio, Eduardo Ortega-Barria
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-01-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	haemophilus influenzae type b (hib) vaccine herd effect latin america pneumococcal conjugate vaccine rotavirus vaccine systematic review
Online Access:	http://dx.doi.org/10.1080/21645515.2018.1514225

Similar Items

Progress towards meningitis prevention in the conjugate vaccines era
by: Cristina Aparecida Borges Laval, et al.

Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine
by: A.E.C.C. de Almeida, et al.
Published: (2005-05-01)

Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China
by: Mengdi Ji, et al.
Published: (2022-11-01)

Long Term Impact of Conjugate Vaccines on <i>Haemophilus influenzae</i> Meningitis: Narrative Review
by: Mary Paulina Elizabeth Slack
Published: (2021-04-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Invasive Haemophilus influenzae Disease, Europe, 1996–2006
by: Shamez Ladhani, et al.
Published: (2010-03-01)

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis
by: Diana C. Caceres, et al.
Published: (2018-05-01)

Vaccine Uptake to Prevent Meningitis and Encephalitis in Shanghai, China
by: Hairenguli Maimaiti, et al.
Published: (2022-11-01)

Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand
by: Surachai Kotirum, et al.
Published: (2017-11-01)

Evaluation of Haemophilus influenzaetype b carrier status among children 10 years after the introduction of Hib vaccine in Brazil
by: Rosemeire Cobo Zanella, et al.
Published: (2015-09-01)

Increasing Incidence of Invasive Haemophilus influenzae Disease in Adults, Utah, USA
by: Matthew P. Rubach, et al.
Published: (2011-09-01)

A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines
by: Shuchen Wang, et al.
Published: (2017-11-01)

Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines
by: Abrham Wondimu, et al.
Published: (2019-12-01)

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries
by: Alen Marijam, et al.
Published: (2022-12-01)

Epidemiological burden of invasive pneumococcal disease in children and adolescents with predisposing risk factors
by: Luiza Helena Falleiros-Arlant, et al.
Published: (2015-09-01)

Newer vaccines (measles-rubella, human papillomavirus, rotavirus, and pneumococcal conjugate vaccine) introduction: Experience from Northern India
by: Madhu Gupta, et al.
Published: (2018-01-01)

Modeling Insights into Haemophilus influenzae Type b Disease, Transmission, and Vaccine Programs
by: Michael L. Jackson, et al.
Published: (2012-01-01)

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
by: Deborah Lehmann, et al.
Published: (2017-12-01)

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution
by: Patricia Izurieta, et al.
Published: (2018-06-01)

Methods of Measuring and Monitoring the Impact of Pentavalent and Streptococcus Pneumonia Vaccines in Iran
by: M Karami, et al.
Published: (2017-02-01)

Monitoring of adverse reaction of Haemophilus influenzae type b vaccine in Songjiang District， Shanghai
by: SHEN Jinhua, et al.
Published: (2022-11-01)

Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialResearch in context
by: Heidi Smith-Vaughan, et al.
Published: (2023-03-01)

Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children
by: Giske Biesbroek, et al.
Published: (2014-02-01)

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018
by: Angel Vila-Córcoles, et al.
Published: (2023-04-01)

Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
by: Maria L. Avila-Aguero, et al.
Published: (2017-07-01)

Changing trends in serotypes of S. pneumoniae isolates causing invasive and non-invasive diseases in unvaccinated population in Mexico (2000-2014)
by: María Noemí Carnalla-Barajas, et al.
Published: (2017-05-01)

Herd immunity alters the conditions for performing dose schedule comparisons: an individual-based model of pneumococcal carriage
by: Alan Yang, et al.
Published: (2019-03-01)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
by: Earnshaw Stephanie R, et al.
Published: (2012-04-01)

Occurrence of Haemophilus influenzae type b (Hib) meningitis in a 2 month-old infant in the Hib vaccination era
by: Yoshiaki Cho, et al.
Published: (2022-06-01)

Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
by: David W. McCormick, et al.
Published: (2011-04-01)

Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America : a review
by: Rishi Desai, et al.
Published: (2011-12-01)

Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
by: Reinaldo de Menezes Martins, et al.
Published: (2008-11-01)

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count
by: Joon Young Song, et al.
Published: (2020-01-01)

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea
by: Eun Hwa Choi, et al.
Published: (2011-04-01)

Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13
by: A. Løvlie, et al.
Published: (2020-01-01)

Human Vaccines in India: Present and Future Perspectives
by: Prasanta Kumar Ghosh
Published: (2019-01-01)

Changes in Invasive Pneumococcal Disease Caused by <em>Streptococcus pneumoniae</em> Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
by: Julia C. Bennett, et al.
Published: (2021-03-01)

New Bacterial Vaccines
by: Işık YALÇIN, et al.
Published: (1996-09-01)

Influenza and pneumococcal vaccination coverage in Latin American patients with systemic lupus erythematosus: a cross-sectional and comparative study
by: Edson Hernán Chiganer, et al.
Published: (2021-07-01)

Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands
by: Gerwin D. Rodenburg, et al.
Published: (2010-05-01)